Skip to main navigation Skip to search Skip to main content

Personal profile

Research interests

Background

The clinical application of liquid biopsies (i.e. biomarkers in body fluids) is challenged by variability introduced during sample collection and processing.

My research focuses on improving the reliability and clinical applicability of liquid biopsy–based diagnostics, with a particular emphasis on understanding and controlling sources of variability in blood-derived biomarkers.

Goal of my research

  • To improve the reproducibility and reliability of blood-based biomarkers by identifying and controlling pre-analytical variability
  • To advance the use of extracellular vesicles (EVs) as biomarkers for disease detection, monitoring, and treatment selection
  • To develop reproducible liquid biopsy workflows and technologies for translation into clinical practice, ensuring real-world applicability and impact

Ultimately, my research aims to improve patient outcomes by enabling earlier disease detection and more precise and effective treatment strategies.

Profile and team
I obtained my industrial PhD in Barcelona and was awarded a Marie Skłodowska-Curie Postdoctoral Fellowship (MSCA-PF) in 2022. In 2025, I received a VENI grant from NWO and I was co-applicant on a funded NWO Perspectief programme: Secret-omics.

My research is embedded within the Amsterdam Vesicle Center (AVC) in Amsterdam UMC, where I lead three research projects and contribute to the supervision and mentoring of students and researchers. In addition, I am co-founder of the start-up company EVcount, where I currently serve as Chief Board Strategy Officer. I served as Chair for the Amsterdam UMC Postdoc Network from 2022-2025. 

I have received multiple awards for my research, including prizes for oral and poster presentations at leading international conferences.

Specialisation

My areas of expertise are:

  • Liquid biopsy biomarker discovery and validation
  • Reproducibility of blood-based biomarker assays
  • Pre-analytical variables in blood collection and plasma processing
  • Detection and characterization of extracellular vesicles (EVs), including EV-RNA biomarkers
  • Flow cytometry-based detection of nanoparticles
  • Translation of biomarker technologies into clinical practice
  • Oncology, cardiovascular disease and endometriosis

Related documents

Education/Academic qualification

PhD, H2020-MSCA-ITN: European Liquid Biopsies Academy (ELBA) , Pangaea Oncology

1 Feb 20181 Feb 2021

Award Date: 28 May 2021

Master, Oncology, Vrije Universiteit Amsterdam

2 Aug 201531 Aug 2017

Award Date: 31 Aug 2017

Bachelor, Biomedical Sciences, Vrije Universiteit Amsterdam

2 Sept 201214 Aug 2015

Award Date: 14 Aug 2015

External positions

Associate Research Scientist, Pangaea Oncology

2 Sept 20171 Feb 2018

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics where Jill Bracht is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or